about
Primary immunodeficiencies underlying fungal infectionsPrimary immune deficiencies - principles of care.Combined immunodeficiency due to MALT1 mutations, treated by hematopoietic cell transplantation.Cytomegalovirus pneumonia as the first manifestation of severe combined immunodeficiency.Modern management of primary T-cell immunodeficiencies.The case for mandatory newborn screening for severe combined immunodeficiency (SCID).Host genetics of invasive Aspergillus and Candida infections.Newborn screening for severe combined immunodeficiency: Evaluation of a commercial T-cell receptor excision circle-based method in Victorian dried blood spots.T-Cell Lymphopenia Detected by Newborn Screening in Two Siblings with an Xq13.1 Duplication.Neonatal Levels of T-cell Receptor Excision Circles (TREC) in Patients with 22q11.2 Deletion Syndrome and Later Disease Features.Laboratory technology for population-based screening for severe combined immunodeficiency in neonates: the winner is T-cell receptor excision circles.First Year of Israeli Newborn Screening for Severe Combined Immunodeficiency-Clinical Achievements and Insights.Screening of neonatal UK dried blood spots using a duplex TREC screening assay.Primary Immunodeficiency Diseases: Need for Awareness and Advocacy in India.Clinical, Immunological, and Molecular Findings in Five Patients with Major Histocompatibility Complex Class II Deficiency from India.11q terminal deletion and combined immunodeficiency (Jacobsen syndrome): Case report and literature review on immunodeficiency in Jacobsen syndrome.Cost-effectiveness analysis of subcutaneous immunoglobulin replacement therapy in Iranian patients with primary immunodeficiencies.
P2860
Q33902831-2FAF38ED-09EC-407C-AAFB-470195B67374Q34700023-1A6ECA85-46C6-4CE2-9358-BFBFE07434F6Q35155236-9854FE3B-1612-4E9C-9CED-7BC81AE9FC4BQ35631796-61B6ED86-F15F-4C2C-B5D2-9F5BBF5563E5Q38175191-A721B699-17B5-4B0D-926E-C2273C36C51BQ38201349-937D7835-7A7F-4EDB-8055-96C26CFE6F8BQ38268925-CEA070F5-4CE1-4BFE-9005-D6832C597BDAQ38598306-E0463E16-0442-4195-A203-B72EDE156F4BQ40108902-451D5E26-8ADA-4F44-A6C2-50B6BADE9A15Q41378782-27082421-064B-40A7-9173-5EF91186EAA7Q42602801-CB055A4B-0DEA-46B0-A45B-A35F66F521D7Q43878336-0FEB79F0-CA98-4C6C-A754-0C8551A09AABQ44445261-697408F5-793D-4484-938F-0657D740329DQ45210860-65B42092-1711-4643-8F20-008AFC1BEF32Q52359747-B46447D2-EA04-4A7B-BEC8-439E2C384154Q52850088-576EF68A-11B4-4117-B9C0-FB01FFE2680AQ55311044-BCEFC769-E7C2-49D1-BC04-7CCC0E70B7AF
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Neonatal screening for severe combined immunodeficiency
@en
Neonatal screening for severe combined immunodeficiency.
@nl
type
label
Neonatal screening for severe combined immunodeficiency
@en
Neonatal screening for severe combined immunodeficiency.
@nl
prefLabel
Neonatal screening for severe combined immunodeficiency
@en
Neonatal screening for severe combined immunodeficiency.
@nl
P2860
P1476
Neonatal screening for severe combined immunodeficiency
@en
P2093
Jennifer M Puck
P2860
P304
P356
10.1097/MOP.0B013E32834CB9B0
P577
2011-12-01T00:00:00Z